There might not be a better place to find winning stocks that can slowly make you wealthy over decades than the healthcare ...

This month, we explore the 125-year-old history of Abbott Laboratories and its most significant milestone to date – the creation of its own independent company, AbbVie. In 1888, a 30-year-old ...

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with ...

When it comes to dividend investing, there are two basic paths you can take. If you can't decide which dividend investing ...

Analysts have mixed opinions on BMY, with a “Moderate Buy” consensus from 25 analysts. Seven rate it a “Strong Buy,” 17 recommend “Hold,” and one suggests “Sell.” The average price target is $59.52, ...

Medtronic has been raising its dividend for 47 consecutive years and it offers a high yield now. Bristol Myers Squibb offers ...

The two largest urban centres in the Northwest are Sligo, the county capital, and Letterkenny in Donegal. The total ...

Some prominent healthcare and consumer stocks have fallen out of favor with the market, so now is the time to pounce on some great deals.

AbbVie, a former division of Abbott Laboratories, became a stand-alone company in 2013. The drugmaker has undergone significant changes since, especially recently with the loss of patent ...

Siatis has been there from the start, having joined Abbott as counsel in 2005. He received promotion after promotion through ...

Let's consider two income-focused corporations whose shares are worth holding on to well beyond next year: AbbVie (NYSE: ABBV) and Abbott Laboratories (NYSE: ABT). Start Your Mornings Smarter!